Document Detail

Effects of rHuEPO therapy on exercise capacity in hemodialysis patients with coronary artery disease.
MedLine Citation:
PMID:  8450597     Owner:  NLM     Status:  MEDLINE    
We investigated the effects of recombinant human erythropoietin (rHuEPO) therapy on exercise capacity by symptom-limited maximal treadmill exercise testing in 9 patients with coronary artery disease who were receiving maintenance hemodialysis. The initial hemoglobin concentration of 7.9 +/- 0.7 g/dl, (mean +/- S.D.) rose to 10.4 +/- 1.1 g/dl, (p < 0.01) after three months of rHuEPO therapy. The partial correction of renal anemia resulted in a significant increase in exercise duration (from 278 +/- 84 sec to 384 +/- 74 sec, p < 0.01) and maximum pressure-rate product (from 228.3 +/- 50.3 mmHg.bpm/10(2) to 262.8 +/- 40.4 mmHg.bpm/10(2), p < 0.01). The maximum exercise-induced ST segment depression significantly decreased after treatment (from 1.3 +/- 0.5 mm to 0.5 +/- 0.5 mm, p < 0.05). These results suggest that the improvement in maximum coronary oxygen supply exceeded the increased maximum myocardial oxygen requirements after the partial correction of renal anemia by rHuEPO therapy in hemodialysis patients with coronary artery disease.
H Hase; Y Imamura; R Nakamura; Y Inishi; K Machii; T Yamaguchi
Related Documents :
18765397 - Effects of the direct lipoprotein-associated phospholipase a(2) inhibitor darapladib on...
6724747 - Influence of left ventricular function and severity of coronary artery disease on exerc...
9462607 - Results of the bruce treadmill test in children after arterial switch operation for sim...
6473517 - Changes in rate-pressure product with physical training of individuals with coronary ar...
16327537 - Anatomy of lower lacrimal canaliculus relative to epicanthoplasty.
11427777 - Response of blood lipids to exercise training alone or combined with dietary intervention.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Japanese circulation journal     Volume:  57     ISSN:  0047-1828     ISO Abbreviation:  Jpn. Circ. J.     Publication Date:  1993 Feb 
Date Detail:
Created Date:  1993-04-14     Completed Date:  1993-04-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7806868     Medline TA:  Jpn Circ J     Country:  JAPAN    
Other Details:
Languages:  eng     Pagination:  131-7     Citation Subset:  IM    
Third Department of Internal Medicine, Toho University Ohashi Hospital, Tokyo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anemia / etiology,  prevention & control
Coronary Disease / complications*
Erythropoietin / therapeutic use*
Exercise Test*
Middle Aged
Physical Endurance / drug effects
Recombinant Proteins / therapeutic use
Renal Dialysis / methods*
Reg. No./Substance:
0/Recombinant Proteins; 11096-26-7/Erythropoietin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The body surface QRST isointegral maps in infants with right ventricular overload.
Next Document:  Iodine 125-phenylpentadecanoic acid and its beta-methyl substitute metabolism in cultured mouse embr...